{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"35"}],"units":"Participants"}],"groups":[{"description":"Capecitabine 1000mg/day for one year\n\ncapecitabine\n\nadjuvant therapy","id":"OG000","title":"Capecitabine"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Entire study population","reportingStatus":"POSTED","timeFrame":"Within 3 years of end of study","title":"Incidence of Second Primary Tumors","type":"SECONDARY","unitOfMeasure":"Participants"}